{"nct_id":"NCT04048135","title":"A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH","status":"COMPLETED","status_verified_date":"2024-02","start_date":"2019-07-29","start_date_type":"ACTUAL","primary_completion_date":"2020-08-28","primary_completion_date_type":"ACTUAL","completion_date":"2022-01-19","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["ETNB"]}